The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org

CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.

Overview of CHAI’s Vaccines Program

CHAI’s Vaccine Markets Team works with vaccine manufacturers, Gavi and other global stakeholders to improve availability, affordability and diversity of supply for vaccines.

The global system of vaccine supply has achieved great progress over the last 25 years, delivering steadily increasing availability and affordability of vaccines to low- and middle-income countries (LMICs), which has enabled significant reductions in under 5 mortalities. The partnership between global organizations (Gavi, UNICEF, WHO, CHAI etc.), vaccine manufacturers and country governments in LMICs has been instrumental to this progress. But the global vaccine ecosystem has also entrenched inequities, with most LMICs having a high reliance on a few vaccine manufacturers located in a handful of countries. A manifestation of this concentration was the delay experienced by many LMICs in accessing Covid-19 vaccines, particularly in Africa. This has led to regional groupings taking action to participate in the vaccine manufacturing ecosystem, again particularly in Africa, being championed by Africa CDC.

CHAI aims to help address this inequity, whilst also maintaining the availability and affordability gains that have had such a dramatic effect in reducing under 5 mortalities. CHAI seeks to achieve this by applying the techniques used successfully in working with global vaccine suppliers and procurers to support the entry of new regional vaccine manufacturers. On the supply-side this entails developing commercial, costing and pricing strategies to support sustainable vaccine manufacturing businesses, whilst on the procurement-side this entails creating policy environments conducive to the procurement from these vaccine manufacturers. In doing so, CHAI’s project will ensure the successful commercial entry of new regional manufacturers, rebalancing in part global vaccine markets whilst also maintaining global vaccine affordability and availability.

Position Overview

The Vaccines Markets team is seeking a Senior Associate to lead our supplier engagements with African vaccine manufacturers. This will entail two specific areas. Firstly, working with African vaccine manufacturers to develop strong commercial, costing and pricing strategies to support their entry into the vaccine market. Secondly, in delivering cross-cutting research across the African vaccine manufacturer ecosystem to inform partners of the key support areas that will enable African manufacturers to be successful.

We are seeking a highly motivated individual with outstanding analytical, strategic, communication and teamwork skills. The successful candidate will adhere to the core CHAI values of resourcefulness, entrepreneurialism, flexibility, independence, humility, and work ethic. The Senior Associate will report to the Senior Program Manager, Vaccine Markets Team.

This role is flexible to be based in an African CHAI program country outside of Senegal, pending Country Leadership approval.

Responsibilities include but are not limited to the following:

• Owning and leading project support to African vaccine manufacturers that address critical business questions such as portfolio planning, go-to market planning, and pricing strategies.
• Leading quantitative and qualitative analysis on the African vaccine manufacturing ecosystem to inform global policy and increase the evidence base for high-impact interventions.
• Proactively developing and managing relationships with key partners to support the growth of the African vaccine manufacturing industry.
• Cultivate relationships with operational counterparts working at donors, global health partners, vaccine procurers and vaccine manufacturers.
• Leading preparation of presentations, reports, and other analyses to be shared with external stakeholders through white papers, conferences, and academic journal articles.
• Creatively scoping and initiating projects that could contribute to further improving the African vaccine manufacturing ecosystem.
• Any other duties as required.

• Analytical – You are comfortable working with large amounts of quantitative and qualitative data and effectively extracting logical conclusions and recommendations from this analysis.
• Intellectually Curious – You proactively seek out knowledge and are interested in developing innovative solutions rather than accepting existing strategies or statements at face-value.
• Insightful – You draw cogent conclusions from large amounts of analysis, sharing what is relevant for real-world challenges in the African vaccine manufacturing ecosystem.
• Practical – You demonstrate judgment in how you allocate your efforts when balancing multiple priorities, focusing on the most decision-critical aspects, and dynamically changing these priorities as required.
• Communicative – You respectfully and effectively navigate varied and sensitive stakeholder environments.
• Responsible – You take pride and ownership in your work and have high standards for what you produce, creating rigorous analysis that can stand up to the scrutiny of internal and external parties.
• Passionate – You are passionate about helping improve the vaccine markets as much as possible.

There is no ‘perfect’ candidate for this role. We are seeking dedicated and passionate individuals who want to make a difference in global health outcomes. Whatever your background, if this role excites you, please apply.

Requirements

• Minimum 5 years of professional experience including in a fast-paced, results-oriented work environment (e.g., strategy consulting, pharmaceuticals, health financing).
• Minimum advanced degree with strong academic performance.
• Proven project management skills and the ability to work independently and handle multiple priorities simultaneously.
• Excellent interpersonal skills, and demonstrated ability to build strong relationships with individuals of varying levels of seniority.
• Clear strategic thinker with very strong problem-solving skills.
• Available for up to 10-20% travel.
• High level of proficiency in Microsoft Office, particularly Excel, PowerPoint, and Word.
• English language fluency, both written and verbal.

Advantages

• French fluency, a significant advantage.
• Experience working remotely with a decentralized team.
• Experience in vaccines or biotechnology R&D, and/or health financing.
• Experience working in or supporting LMICs.
• Prior knowledge or experience of global health partners within the vaccine ecosystem.

#jobreference2 #region4